4 completed, 2 terminated, 1 active not recruiting. 7 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 4, Terminated 2, Active not recruiting 1 |
| Phase 2 | 6 | Completed 3, Terminated 2, Active not recruiting 1 |
Follow Genethon: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Gene Therapy Using a Lentiviral Vector to Treat X-linked Chronic Granulomatous Disease Lentiviral G1XCGD Gene Therapy - Granulomatous Disease, Chronic, X-linked | Phase 1 / Phase 2 | Completed | University of California, Los Angeles | 10 | 2015-10-29 | 2025-05-02 |
| Long Term Safety Follow up of Haematopoietic Stem Cell Gene Therapy for the Wiskott Aldrich Syndrome Autologous CD34+ cells transduced with WASP lentiviral vector - Wiskott-Aldrich Syndrome | Phase 1 / Phase 2 | Active not recruiting | Genethon | 10 | 2014-09-01 | 2021-06-03 |
| Gene Therapy for X-linked Chronic Granulomatous Disease (X-CGD) X vivo gene therapy - X-Linked Chronic Granulomatous Disease | Phase 1 / Phase 2 | Terminated | Genethon | 3 | 2013-06-24 | 2026-04-13 |
| Gene Therapy for X-linked Chronic Granulomatous Disease X vivo gene therapy - X-Linked Chronic Granulomatous Disease | Phase 1 / Phase 2 | Terminated | Genethon | 3 | 2013-06-24 | 2026-04-13 |
| Gene Therapy for WAS Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene - Wiskott-Aldrich Syndrome | Phase 1 / Phase 2 | Completed | Genethon | 5 | 2011-05-01 | 2018-05-22 |
| Gene Therapy for Wiskott-Aldrich Syndrome (WAS) Autologous CD34 positive cells transduced with a lentiviral vector containing human WAS gene - Wiskott-Aldrich Syndrome | Phase 1 / Phase 2 | Completed | Genethon | 6 | 2011-03-01 | 2021-06-03 |
| Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C AAV1-gamma-sarcoglycan vector injection - Limb Girdle Muscular Dystrophy Type 2C, Gamma-sarcoglycanopathy | Phase 1 | Completed | Genethon | 9 | 2006-11-01 | 2011-04-29 |
Granulomatous Disease, Chronic (3) · Wiskott-Aldrich Syndrome (3) · Primary Immunodeficiency Diseases (2) · Limb-girdle muscular dystrophy, type 2C (1) · Neuromuscular Diseases (1) · Rare Diseases (1)
France (4) · United Kingdom (3) · United States (1)
Adrian Thrasher, MD, PHD (1) · Caroline Y. Kuo, MD (1) · Donald B. Kohn, MD (1) · Emma Morris, MD, PHD (1) · Hubert Serve, MD, PHD (1) · Janine Reichenbach, MD (1) · Serge Herson, Prof (1)
PMID 35075289, PMID 28716862, PMID 29664709
2009 (1), P01HL073104 (1)